This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for š-Thalassaemia Patient at UCLH
Shirley D’Sa, Professor of Haematology at United KingdomUnited Kingdom, reposted from University College London Hospitals NHS Foundation Trust on LinkedIn:
”This is fantastic!!!”
Quoting University College London Hospitals NHS Foundation Trust‘s post:
”A UCLH patient with beta thalassaemia has spent her first ever Christmas without needing to plan her life around blood transfusions after a gene-editing therapy has left her able to produce her own red blood cells.
Kavita Mehta (pictured) has transfusion-dependent beta thalassaemia (TDT), which means she does not produce enough haemoglobin, the protein in red blood cells that carries oxygen round the body.
This means she usually has to have a blood transfusion every three weeks.
Kavita said: āA life of regular blood transfusions is all I know.
I cannot believe that doctors have already seen signs that I am now able to produce my own red blood cells.
I canāt tell you what this means to me, and to my family who have had to watch me go through this and care for me.
And more than anything, I am thrilled that this drug is available on the NHS and may help patients who are much younger than me live a life independent of transfusionsā.
UCLH haematology consultant Ben Carpenter, who has been treating Kavita, said: āWe are pleased with the way things are going for our first patient.
She had a challenging time in hospital but is now feeling much better.
It has been more than two weeks since Kavita’s last red cell transfusion, and her levels are continuing to rise independently.
We are now seeing normal red blood cells being produced by her own bone marrow for the first time since she was born.ā
Find out more.”
Stay updated with Hemostasis Today.
-
Jul 10, 2026, 20:47New Machine Learning Models Improve Prediction of Thrombosis and Bleeding in Cancer – JTH
-
Jul 10, 2026, 20:39Evangelia Petsalaki: New Systems Biology Approach Identifies Biomarkers in Thrombotic APS
-
Jul 10, 2026, 20:29Wolfgang Miesbach: Celebrating Pantep Angchaisuksiriās Transformative Leadership of the ISTH
-
Jul 10, 2026, 20:17Amy Pantaleo: How Staffing Shortages Are Changing Hemostasis Laboratories
-
Jul 10, 2026, 20:15Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
-
Jul 10, 2026, 20:15Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
-
Jul 10, 2026, 20:13Shahin Alam: Is Your Coagulant Limiting Your Water Treatment Performance?
-
Jul 10, 2026, 20:12Ali Bozorgi: Our Meta-Analysis on Oral Anticoagulation After AF Ablation Featured in EP Europace
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership